ArticleBritish journal of cancer1999

Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines.

U Vanhoefer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.